Loading...
Derniers dépôts
-
Sébastien Mulé, Littisha Lawrance, Younes Belkouchi, Valérie Vilgrain, Maité Lewin, et al.. Generative adversarial networks (GAN)-based data augmentation of rare liver cancers: The SFR 2021 Artificial Intelligence Data Challenge. Diagnostic and Interventional Imaging, 2023, 104 (1), pp.43-48. ⟨10.1016/j.diii.2022.09.005⟩. ⟨hal-03907631⟩
-
Sophie Renet, Marie-Camille Chaumais, Mélanie Gallant-Dewavrin, Emmanuelle Jouet, Yvonnick Bezie, et al.. Knowledge exchange between patient and pharmacist: a mixed methods study to explore the role of pharmacists in patient education and counselling in asthma and pulmonary arterial hypertension. Annales Pharmaceutiques Françaises, 2022, ⟨10.1016/j.pharma.2022.06.005⟩. ⟨hal-03712124⟩
-
Maud Voisin, Philippe de Médina, Arnaud Mallinger, Florence Dalenc, Emilie Huc-Claustre, et al.. Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor. Proceedings of the National Academy of Sciences of the United States of America, 2017, 114 (44), pp.E9346-E9355. ⟨10.1073/pnas.1707965114⟩. ⟨hal-02316171⟩
-
Faten Merhi, Karla Alvarez-Valadez, Jenifer Trepiana, Claire Lescoat, Alexis Groppi, et al.. Targeting CAMKK2 and SOC Channels as a Novel Therapeutic Approach for Sensitizing Acute Promyelocytic Leukemia Cells to All-Trans Retinoic Acid. Cells, 2021, 10 (12), pp.3364. ⟨10.3390/cells10123364⟩. ⟨hal-03457279⟩
-
Dorian Culié, Quentin Lisan, Charlotte Leroy, Anouchka Modesto, Renaud Schiappa, et al.. Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric study. European journal of cancer, 1970, 143, pp.168-177. ⟨10.1016/j.ejca.2020.10.034⟩. ⟨hal-03618860⟩
-
Jean-Emmanuel Kurtz, Xavier Buy, Frédéric Deschamps, Erik Sauleau, Amine Bouhamama, et al.. CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment. European Journal of Cancer, 2021, 143, pp.78-87. ⟨10.1016/j.ejca.2020.10.035⟩. ⟨hal-03623642⟩
-
Sylvain Manfredi, Anthony Turpin, David Malka, Emilie Barbier, Pierre Laurent-Puig, et al.. Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III study. Digestive and Liver Disease, 2020, 52 (10), pp.1143-1147. ⟨10.1016/j.dld.2020.06.034⟩. ⟨hal-04548048⟩
-
Sarah Atallah, Odile Casiraghi, Nicolas Fakhry, Michel Wassef, Emmanuelle Uro-Coste, et al.. A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors. European journal of cancer, 2020, 130, pp.241-249. ⟨10.1016/j.ejca.2020.01.023⟩. ⟨hal-03599053⟩
-
Nicolas Penel, Olivier Mir, Jennifer Wallet, Isabelle Ray-Coquard, Axel Le Cesne, et al.. A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib. European Journal of Cancer, 2020, 126, pp.45-55. ⟨10.1016/j.ejca.2019.12.001⟩. ⟨hal-03623680⟩
-
Antonin Levy, Cécile Le Péchoux, Hitesh Mistry, Isabelle Martel-Lafay, Andrea Bezjak, et al.. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial. Journal of Thoracic Oncology, 2019, 14 (2), pp.294-297. ⟨10.1016/j.jtho.2018.09.019⟩. ⟨hal-04508663⟩
-
Liana Hardy, Brindha Kannan, Manuel Rigon, Genevieve Benton-Hawthorn, Renato Previdelli, et al.. Canine Mammary Tumours (CMTs) exploit Mitochondrial Cholesterol for aggressive reprogramming. Biochimica et Biophysica Acta - Molecular Basis of Disease, 2024, 1871 (2), pp.167546. ⟨10.1016/j.bbadis.2024.167546⟩. ⟨hal-04805257⟩